Core Outcome Set for Clinical Trials on Coronavirus Disease 2019 (COS-COVID)Xinyao Jin, Bo Pang, Junhua Zhang et al.|Engineering|2020Cited by 122
Toripalimab plus bevacizumab versus sorafenib as first-line treatment for advanced hepatocellular carcinoma (HEPATORCH): a randomised, open-label, phase 3 trialYing–Hong Shi, Enxiao Li, Xiangdong Hua et al.|The Lancet. Gastroenterology & hepatology|2025Cited by 39
Bacteroidetes promotes esophageal squamous carcinoma invasion and metastasis through LPS-mediated TLR4/Myd88/NF-κB pathway and inflammatory changesZhongbing Wu, Jing Li, Jianxin Guo et al.|Scientific Reports|2024Cited by 20
Mechanism of Liver Regeneration During ALPPSYao Xiao, Liansheng Gong, Hongjuan Xu et al.|Frontiers in Cell and Developmental Biology|2022Cited by 9